Clinical trial
Nesiritide and Vo2 Max in Heart Failure Patients
NCT00240084 · University of Rochester, Other · Completed
Key facts
| NCT number | NCT00240084 |
|---|---|
| Title | Nesiritide and Vo2 Max in Heart Failure Patients |
| Official title | Nesiritide and Vo2 Max in Heart Failure Patients |
| Lead sponsor | University of Rochester, Other |
| Collaborators | Scios, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Heart Failure |
| Intervention type | Drug |
| Interventions | nesiritide (Natrecor(TM)) |
| Enrollment | 20 |
| Start date | Jul 1, 2003 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Oct 17, 2005 |
| Last update posted | Jun 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: